close
close

Serina Therapeutics Reports Second Quarter 2024 Financial Results, Provides Business Highlights

Posted on by Vaseline
Serina Therapeutics Reports Second Quarter 2024 Financial Results, Provides Business Highlights

HUNTSVILLE, August 9, 2024 (GLOBE NEWSWIRE) — Serina Therapeutica (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug delivery technology, today reported financial results for the quarter ended June 30, 2024 and provided business highlights.

Recent highlights

Related Posts